+

WO1999044579A3 - Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique - Google Patents

Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique Download PDF

Info

Publication number
WO1999044579A3
WO1999044579A3 PCT/FR1999/000430 FR9900430W WO9944579A3 WO 1999044579 A3 WO1999044579 A3 WO 1999044579A3 FR 9900430 W FR9900430 W FR 9900430W WO 9944579 A3 WO9944579 A3 WO 9944579A3
Authority
WO
WIPO (PCT)
Prior art keywords
activity
channel
composition
compound inhibiting
calcium channel
Prior art date
Application number
PCT/FR1999/000430
Other languages
English (en)
Other versions
WO1999044579A2 (fr
Inventor
Isabelle Nonotte
Lionel Breton
Original Assignee
Oreal
Isabelle Nonotte
Lionel Breton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Isabelle Nonotte, Lionel Breton filed Critical Oreal
Priority to EP99937868A priority Critical patent/EP1059912A2/fr
Priority to CA002322149A priority patent/CA2322149A1/fr
Priority to JP2000534182A priority patent/JP2002505268A/ja
Priority to AU32564/99A priority patent/AU3256499A/en
Publication of WO1999044579A2 publication Critical patent/WO1999044579A2/fr
Publication of WO1999044579A3 publication Critical patent/WO1999044579A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à l'utilisation d'au moins un composé inhibant partiellement ou totalement l'activité d'un canal sodium ou d'un canal calcium dans une composition cosmétique et/ou pharmaceutique, pour augmenter le seuil de tolérance de la peau, particulièrement des peaux sensibles ou des peaux intolérantes et plus spécialement pour supprimer les démangeaisons, les prurits, les tiraillements, les picotements et/ou les érythèmes.
PCT/FR1999/000430 1998-03-06 1999-02-25 Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique WO1999044579A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99937868A EP1059912A2 (fr) 1998-03-06 1999-02-25 Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique
CA002322149A CA2322149A1 (fr) 1998-03-06 1999-02-25 Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique
JP2000534182A JP2002505268A (ja) 1998-03-06 1999-02-25 局所使用組成物におけるナトリウムチャンネル活性阻害化合物の使用
AU32564/99A AU3256499A (en) 1998-03-06 1999-02-25 Use of a compound inhibiting the activity of a sodium channel and a calcium channel in a composition for topical use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR98/02783 1998-03-06
FR9802783A FR2775594B1 (fr) 1998-03-06 1998-03-06 Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique

Publications (2)

Publication Number Publication Date
WO1999044579A2 WO1999044579A2 (fr) 1999-09-10
WO1999044579A3 true WO1999044579A3 (fr) 2000-01-06

Family

ID=9523759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1999/000430 WO1999044579A2 (fr) 1998-03-06 1999-02-25 Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique

Country Status (6)

Country Link
EP (1) EP1059912A2 (fr)
JP (1) JP2002505268A (fr)
AU (1) AU3256499A (fr)
CA (1) CA2322149A1 (fr)
FR (1) FR2775594B1 (fr)
WO (1) WO1999044579A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610683B2 (en) * 1996-09-12 2003-08-26 Idun Pharmaceuticals, Inc. Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
RU2161480C1 (ru) * 1999-11-04 2001-01-10 Щеткина Наталья Иосифовна Способ приготовления состава для талассотерапии
FR2815539B1 (fr) * 2000-10-23 2003-02-14 Silab Sa Principe actif riche en isoflavones, son procede d'extraction et ses applications cosmetiques
FR2823669B1 (fr) 2001-04-23 2004-03-26 Oreal Procede pour augmenter le seuil de tolerance d'une peau sensible ou intolerante
EP1749528A1 (fr) * 2005-08-05 2007-02-07 Pharma C S.A. Combinaisons pharmaceutiques comprenant un agoniste de l'opioide mu et un inhibiteur de la production de monoxide d'azote
GB0619176D0 (en) * 2006-09-29 2006-11-08 Lectus Therapeutics Ltd Ion channel modulators & uses thereof
WO2010110428A1 (fr) * 2009-03-27 2010-09-30 協和発酵キリン株式会社 Agent pour prévenir et/ou traiter le prurit
KR101099550B1 (ko) * 2009-04-02 2011-12-28 대한민국 봉독을 유효성분으로 하는 상처 또는 화상 치료용 조성물
JP5562716B2 (ja) * 2010-05-12 2014-07-30 花王株式会社 電位依存性カチオンチャネル抑制剤
EP2638908A1 (fr) * 2012-03-16 2013-09-18 Phytotox SpA Poison paralysant de mollusque
CN105233286B (zh) * 2015-09-10 2018-10-30 上海交通大学医学院 含酸敏感离子通道调控剂的制剂及其在治疗瘙痒中的用途

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
JPS63280006A (ja) * 1987-05-12 1988-11-17 Yakult Honsha Co Ltd 皮膚刺激感抑制剤及びこれを配合してなる化粧料
JPH01238509A (ja) * 1988-03-16 1989-09-22 Shiseido Co Ltd 皮膚外用剤
JPH07173078A (ja) * 1993-12-21 1995-07-11 Taisho Pharmaceut Co Ltd 鎮痒剤組成物
JPH07291856A (ja) * 1994-04-28 1995-11-07 Yuutoku Yakuhin Kogyo Kk 皮膚疾患治療乳剤
WO1996019182A1 (fr) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052513A (en) * 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
JPS63280006A (ja) * 1987-05-12 1988-11-17 Yakult Honsha Co Ltd 皮膚刺激感抑制剤及びこれを配合してなる化粧料
JPH01238509A (ja) * 1988-03-16 1989-09-22 Shiseido Co Ltd 皮膚外用剤
JPH07173078A (ja) * 1993-12-21 1995-07-11 Taisho Pharmaceut Co Ltd 鎮痒剤組成物
JPH07291856A (ja) * 1994-04-28 1995-11-07 Yuutoku Yakuhin Kogyo Kk 皮膚疾患治療乳剤
WO1996019182A1 (fr) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations et procedes pour diminuer l'irritation de la peau

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 111, no. 18, 30 October 1989, Columbus, Ohio, US; abstract no. 160001, HIRAKI, YOSHIO ET AL: "Cosmetics containing inhibitors of skin irritating agents" XP002087990 *
CHEMICAL ABSTRACTS, vol. 112, no. 14, 2 April 1990, Columbus, Ohio, US; abstract no. 124944, FUJII, SEISHIRO ET AL: "Cosmetic skin preparations containing calmodulin inhibitors or calcium inhibitors" XP002087991 *
CHEMICAL ABSTRACTS, vol. 123, no. 16, 16 October 1995, Columbus, Ohio, US; abstract no. 208788, SUGITA, KIMIKO ET AL: "Itching-controlling agents containing calcium hydrogen phosphate particles" XP002087989 *
CHEMICAL ABSTRACTS, vol. 124, no. 12, 18 March 1996, Columbus, Ohio, US; abstract no. 156030, DOI, SHIGEO ET AL: "Skin disease therapeutic emulsions containing urea, diphenhydramine, and lidocaine" XP002087988 *
DR. W. FORTH: "Lokalanästhetika", ALLGEMEINE UND SPEZIELLE PHARMAKOLOGIE UND TOXIKOLOGIE, pages 490 - 492, XP002087987 *

Also Published As

Publication number Publication date
CA2322149A1 (fr) 1999-09-10
FR2775594A1 (fr) 1999-09-10
AU3256499A (en) 1999-09-20
EP1059912A2 (fr) 2000-12-20
JP2002505268A (ja) 2002-02-19
WO1999044579A2 (fr) 1999-09-10
FR2775594B1 (fr) 2002-12-27

Similar Documents

Publication Publication Date Title
WO1999004752A3 (fr) Procede pour le traitement de la pigmentation de la peau
CA2286409A1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
AU747599C (en) Antitumor agents
ZA991999B (en) Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation.
ZA9811805B (en) Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis.
MXPA00007388A (es) Metodos para tratar la pigmentacion de la piel.
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
WO1999044579A3 (fr) Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique
ZA964552B (en) Compositions for topical application to skin.
DK0884997T3 (da) Sammensætninger, der indeholder en afsvampnings- og en svovlforbindelse
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
WO2002098347A3 (fr) Procedes et compositions ayant une incidence sur la melanogenese
TWI256292B (en) Reduction inhibitory agent for active oxygen eliminating activity
TWI256892B (en) Plasminogen activator inhibitor and external preparation for skin comprising the same
EP0861663A3 (fr) Agent inhibiteur des ostéoclastes comprenant l'interleukin-18
EP0880964A3 (fr) Inhibition de l'aldose reductase pour la prévention ou la réversion de la cardiomyopathie diabétique
WO2002023985A3 (fr) Combinaisons de principes actifs servant a proteger des peaux d'animaux et le cuir
WO2001062208A3 (fr) Agents cosmetiques topiques contenant des 2-hydrazino-1,3-heteroazols
WO2000021485A3 (fr) Polyurethanes protecteurs topiques de la peau
MXPA99011362A (es) Empleo de 2-mercapto-piridin-n-oxido.
AU4630599A (en) Perfume composition
EP1068868A3 (fr) Compositions synergiques comportant l'ascorbate et la lysine pour des états associés à la dégénération de la matrice extracellulaire
WO2000033787A3 (fr) Composition cosmetique deodorante
WO2001047505A3 (fr) Utilisation d'azoles dans la prevention du cancer de la peau
GB9819991D0 (en) Antiperspirant composition and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999937868

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2322149

Country of ref document: CA

Ref country code: CA

Ref document number: 2322149

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 09623570

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999937868

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999937868

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载